Translating Evidence to Practice to Improve Outcomes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Episode 3
Experts discuss which factors are considered when choosing treatment options for patients with R/R DLBCL as well as reviewing the mechanism of tafasitamab.